Asian Spectator

Times Advertising

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner

  • Written by PR Newswire Asia - Asian Spectator

SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) patients treated with paxalisib and to seek...

Magazine

Jangan asal FOMO padel: Tidak semua olahraga cocok buat tubuh kita

● Pilihan olahraga perlu menyesuaikan tipe tubuh.● Cara ini akan memaksimalkan aktivitas fisik dan kurangi risiko cedera.● Tipe tubuh memengaruhi kemampuan fisik membentuk otot dan m...

Bahaya bertanya ke AI: Separuh jawaban kesehatan menyesatkan, meski terdengar meyakinkan

Ilustrasi AI.Who is Danny/Shutterstock.comBayangkan kamu baru saja didiagnosis kanker stadium awal. Sebelum janji temu berikutnya dengan dokter, kamu bertanya ke chatbot berbasis kecerdasan buatan (AI...

Why Contractors Suction Hose Solutions Are Essential For Heavy-Duty Fluid Handling

In industries where materials move as relentlessly as time itself, equipment must match that intensity. Whether on construction sites, agricultural operations, or large-scale industrial setups, flui...